...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Name Confusion

Why the F dont they just change the name to stop all this confusion?

It is one of the cheaper corporate fixes. Not only cant they sell or partner their companies, they cant even avoid confusion about their names, this group is beyond frustrating.

Maybe DM will address this on this on the CC - ha ha 

Share
New Message
Please login to post a reply